Correlation between human leukocyte antigen ligands and killer cell immunoglobulin-like receptors in aplastic anemia patients from Shaanxi Han.


Journal

Immunogenetics
ISSN: 1432-1211
Titre abrégé: Immunogenetics
Pays: United States
ID NLM: 0420404

Informations de publication

Date de publication:
10 2023
Historique:
received: 23 03 2023
accepted: 15 07 2023
medline: 22 9 2023
pubmed: 18 8 2023
entrez: 17 8 2023
Statut: ppublish

Résumé

Regulating natural killer (NK) cell responses in hematological malignancies largely depend on molecular interactions between killer cell immunoglobulin-like receptors (KIR) and human leukocyte antigen (HLA) class I ligands. The goal of the current study was to examine the key functions of KIR genes, gene combinations of KIR-HLA, and KIR genotypes in genetic predisposition to aplastic anemia (AA). Herein, the genotyping of 16 KIR genes and HLA-A, -B, and -C ligands were performed in 72 AA patients and 150 healthy controls using PCR evaluations with sequence-specific primers using standard assays. According to the obtained results, AA patients had an increased incidence of activating KIR and KIR2DS4 (P = 0.465 × 10

Identifiants

pubmed: 37592108
doi: 10.1007/s00251-023-01316-6
pii: 10.1007/s00251-023-01316-6
doi:

Substances chimiques

Ligands 0
Histocompatibility Antigens 0
HLA Antigens 0
Histocompatibility Antigens Class II 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

445-454

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Ashouri E, Ghaderi A, Reed EF, Rajalingam R (2009) A novel duplex SSP-PCR typing method for KIR gene profiling. Tissue Antigens 74(1):62–67. https://doi.org/10.1111/j.1399-0039.2009.01259.x
doi: 10.1111/j.1399-0039.2009.01259.x pubmed: 19392793
Augusto DG, O’ Connor GM, Lobo-Alves SC, Bass S, Martin MP, Carrington M, McVicar DW, Peazl-Erler ML (2015) Pemphigus is associated with KIR3DL2 expression levels and provides evidence that KIR3DL2 may bind HLA-A3 and A11 in vivo. Eur J Immunol 45(7):2052–2060. https://doi.org/10.1002/eji.201445324
doi: 10.1002/eji.201445324 pubmed: 25867094 pmcid: 4530613
Augusto DG, Petzl-Erler ML (2015) KIR and HLA under pressure: evidences of coevolution across worldwide populations. Hum Genet 134(9):929–940. https://doi.org/10.1007/s00439-015-1579-9
doi: 10.1007/s00439-015-1579-9 pubmed: 26099314
Blokhuis JH, Hilton HG, Guethlein LA, Norman PJ, Nemat-Gorgani N, Nakimuli A, Chazara O, Moffett A, Parham P (2017) KIR2DS5 allotypes that recognize the C2 epitope of HLA-C are common among Africans and absent from Europeans. Immun Inflamm Dis 5(4):461–468. https://doi.org/10.1002/iid3.178
doi: 10.1002/iid3.178 pubmed: 28685972 pmcid: 5691316
Cai J, Liu X, Wang J, Tian W (2012) Killer cell immunoglobulin-like receptor (KIR) genes in 4 distinct populations and 51 families in mainland China. Hum Immunol 73(10):1023–1030. https://doi.org/10.1016/j.humimm.2012.07.324
doi: 10.1016/j.humimm.2012.07.324 pubmed: 22836043
Cooley S, Weisdorf DJ, Guethlein LA, Klein JP, Wang T, Le CT, Marsh SG (2010) Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia. Blood 116(14):2411–2419. https://doi.org/10.1182/blood-2010-05-283051
doi: 10.1182/blood-2010-05-283051 pubmed: 20581313 pmcid: 2953880
Gonzalez-Galarza FF, McCabe A, Santos EJMD, Jones J, Takeshita L, Ortega-Rivera ND, Cid-Pavon GMD (2020) Allele frequency net database (AFND) 2020 update: gold-standard data classification, open access genotype data and new query tools. Nucleic Acids Res 48(D1):D783-788. https://doi.org/10.1093/nar/gkq1029
doi: 10.1093/nar/gkq1029 pubmed: 31722398
Graef T, Moesta AK, Norman PJ, Abi-Rached L, Vago L, Older Aguilar AM, Parham P (2009) KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C. J Exp Med 206(11):2557–2572. https://doi.org/10.1084/jem.20091010
doi: 10.1084/jem.20091010 pubmed: 19858347 pmcid: 2768862
Gwozdowicz S, Nestorowicz K, Graczyk-Pol E, Szlendak U, Rogatko-Karos M, Mika-Witkowska R, Nowak J (2019) KIR specificity and avidity of standard and unusual C1, C2, Bw4, Bw6 and A3/11 amino acid motifs at entire HLA: KIR interface between NK and target cells, the functional and evolutionary classification of HLA class I molecules. Int J Immunogenet 46(4):217–231. https://doi.org/10.1111/iji.12433
doi: 10.1111/iji.12433 pubmed: 31210416
Hansasuta P, Dong T, Thananchai H, Weekes M, Willberg C, Aldemir H, Rowland-Jones S, Braud VM (2004) Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific. Eur J Immunol 34(6):1673–1679. https://doi.org/10.1002/eji.200425089
doi: 10.1002/eji.200425089 pubmed: 15162437
Hou Y, Zhang C, Xu D, Sun H (2015) Association of killer cell immunoglobulin receptor and human leucocyte antigen-Cw gene combinations with systemic lupus erythematosus. Clin Exp Immunol 180(2):250–254. https://doi.org/10.1111/cei.12582
doi: 10.1111/cei.12582 pubmed: 25581336 pmcid: 4408160
Jamil KM, Khakoo SI (2011) KIR/HLA interactions and pathogen immunity. J Biomed Biotechnol 2011:298348. https://doi.org/10.1155/2011/298348
doi: 10.1155/2011/298348 pubmed: 21629750 pmcid: 3100571
Jobim M, Chagastelles P, Salim PH, Portela P, Wilson TJ, Curti AG, Jobim MR (2010) Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes. Hum Immunol 71(8):799–803. https://doi.org/10.1016/j.humimm.2010.05.014
doi: 10.1016/j.humimm.2010.05.014 pubmed: 20580654
Jost S, Altfeld M (2013) Control of human viral infections by natural killer cells. Annu Rev Immunol 31:163–194. https://doi.org/10.1146/annurev-immunol-032712-100001
doi: 10.1146/annurev-immunol-032712-100001 pubmed: 23298212
Kordasti S, Marsh J, AI-Khan S, Jiang J, Smith A, Mohamedali A, Mufti GJ, (2012) Functional characterization of CD4+ T cells in aplastic anemia. Blood 119(9):2033–2043. https://doi.org/10.1182/blood-2011-08-368308
doi: 10.1182/blood-2011-08-368308 pubmed: 22138514
Liu C, Sun Y, Shao Z (2019) Current concepts of the pathogenesis of aplastic anemia. Curr Pharm Des 25(3):236–241. https://doi.org/10.2174/1381612825666190313113601
doi: 10.2174/1381612825666190313113601 pubmed: 30864496
Machado-Sulbaran AC, Ramírez-Dueñas MG, Navarro-Zarza JE, Muñoz-Valle JF, Mendoza-Carrera F, Baños-Hernández CJ, Sánchez-Hernández PE (2019) KIR/HLA gene profile implication in systemic sclerosis patients from Mexico. J Immunol Res 2019:6808061. https://doi.org/10.1155/2019/6808061
doi: 10.1155/2019/6808061 pubmed: 30723749 pmcid: 6339729
Martin MP, Qi Y, Gao X, Yamada E, Martin JN, Pereyra F, Carrington M (2007) Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet 39(6):733–740. https://doi.org/10.1038/ng2035
doi: 10.1038/ng2035 pubmed: 17496894 pmcid: 4135476
Middleton D, Gonzelez F (2010) The extensive polymorphism of KIR genes. Immunology 129(1):8–19. https://doi.org/10.1111/j.1365-2567
doi: 10.1111/j.1365-2567 pubmed: 20028428 pmcid: 2807482
O’ Connor GM, Guinan KJ, Cunningham RT, Middleton D, Parham P, Gardiner CM, (2007) Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells. J Immunol 178(1):235–241. https://doi.org/10.4049/jimmunol.178.1.235
doi: 10.4049/jimmunol.178.1.235 pubmed: 17182560
Pamuk GE, Tozkir H, Uyanik MS, Gurkan H, Duymaz J, Pamuk ON (2015) Natural killer cell killer immunoglobulin-like gene receptor polymorphisms in non-Hodgkin lymphoma: possible association with clinical course. Leuk Lymphoma 56(10):2902–2907. https://doi.org/10.3109/10428194.2015.1014361
doi: 10.3109/10428194.2015.1014361 pubmed: 25699652
Peng H, Tian Z (2018) NK cells in liver homeostasis and viral hepatitis. Sci China Life Sci 61(12):1477–1485. https://doi.org/10.1007/s11427-018-9407-2
doi: 10.1007/s11427-018-9407-2 pubmed: 30421296
Rajalingam R (2018) Diversity of killer cell immunoglobulin-like receptors and disease. Clin Lab Med 38(4):637–673. https://doi.org/10.1016/j.cll.2018.08.011
doi: 10.1016/j.cll.2018.08.011 pubmed: 30420058
Shahsavar F, Tajik N, Entezami KZ, Fallah Radjabzadeh M, Asadifar B, Alimoghaddam K, Ghavamzadeh A (2010) KIR2DS3 is associated with protection against acute myeloid leukemia. Iran J Immunol 7(1):8–17
pubmed: 20371915
Shi L, Zhang H, Shen Y, Dong Y, Li Y, Dong Z, Yu J (2013) Distribution of KIR genes in Han population in Yunnan Province: comparison with other Han populations in Chian. Int J Immunogenet 40(5):361–368. https://doi.org/10.1111/iji.12046
doi: 10.1111/iji.12046 pubmed: 23594113
Theeranawakam A, Vejbaesya S, Khuhapinant A, Sae-Tam P (2021) Killer cell immunoglobulin-like receptors in Thai patients with multiple myeloma. Asian Pac J Allergy Immunol.  https://doi.org/10.12932/AP-130520-0842
Tuttolomondo A, Di Raimondo D, Pecoraro R, Casuccio A, Di Bona D, Aiello A, Pinto A (2019) HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute ischemic stroke. J Neuroinflammation 16(1):88. https://doi.org/10.1186/s12974-019-1469-5
doi: 10.1186/s12974-019-1469-5 pubmed: 30995924 pmcid: 6471781
Uhrberg M, Valiante NM, Shum BP, Shilling HG, Lienert-Weidenbach K, Corliss B, Tyan D, Lanier LL, Parham P (1997) Human diversity in killer cell inhibitory receptor genes. Immunity 7(6):753–763. https://doi.org/10.1016/s1074-7613(00)80394-5
doi: 10.1016/s1074-7613(00)80394-5 pubmed: 9430221
Vierra-Green C, Roe D, Hou L, Hurley CK, Rajalingam R, Reed E, Lebedeva T (2012) Allele-level haplotype frequencies and pairwise linkage disequilibrium for 14 KIR loci in 506 European-American individuals. PLoS One 7(11):e47491. https://doi.org/10.1371/journal.pone.0047491
doi: 10.1371/journal.pone.0047491 pubmed: 23139747 pmcid: 3489906
Wang HD, Zhang FX, Shen CM, Wu YM, Lv YG, Xie ST, Zhu BF (2012) The distribution of genetic diversity of KIR genes in the Chinese Mongolian population. Hum Immunol 73(10):1031–1038. https://doi.org/10.1016/j.humimm.2012.07.317
doi: 10.1016/j.humimm.2012.07.317 pubmed: 22836038
Wang HD, Zhu BF, Shen CM, Fan AY, Song TN, Liu JL, Yan CX (2011) Diversity distribution of killer cell immunoglobulin-like receptor genes and their ligands in the Chinese Shaanxi Han population. Hum Immunol 72(9):733–740. https://doi.org/10.1016/j.humimm.2011.04.003
doi: 10.1016/j.humimm.2011.04.003 pubmed: 21708203
Wang T, Shen C, Chen L, Liu S, Ji Y (2017) Association of human leukocyte antigen polymorphisms with occult hepatitis B virus infection in a Shaanxi Han population. J Gene Med 19:9–10. https://doi.org/10.1002/jgm.2987
doi: 10.1002/jgm.2987
Warrington KJ, Takemura S, Goronzy JJ, Weyand CM (2001) CD4+, CD28-T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems. Arthritis Rheum 44(1):13–20. https://doi.org/10.1002/1529-0131(200101)44:01%3c13::AID-ANR3%3e3.0.CO;2-6
doi: 10.1002/1529-0131(200101)44:01<13::AID-ANR3>3.0.CO;2-6 pubmed: 11212151
Yang C, Zhang X (1991) Incidence survey of aplastic anemia in China. Chin Med Sci J 6(4):203–207
pubmed: 1813058
Young NS, Kaufman DW (2008) The epidemiology of acquired aplastic anemia. Haematologica 93(4):489–492. https://doi.org/10.3324/haematol.12855
doi: 10.3324/haematol.12855 pubmed: 18379007
Zhang Y, Wang B, Ye S, Liu S, Liu M, Shen C, Qi J (2010) Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease. Leuk Res 34(1):55–58. https://doi.org/10.1016/j.leukres.2009.04.022
doi: 10.1016/j.leukres.2009.04.022 pubmed: 19450876
Zhen J, Wang D, He L, Zou H, Xu Y, Gao S, Deng Z (2014) Genetic profile of KIR and HLA in southern Chinese Han population. Hum Immunol 75(1):59–64. https://doi.org/10.1016/j.humimm.2013.09.006
doi: 10.1016/j.humimm.2013.09.006 pubmed: 24055695
Zhu BF, Wang HD, Shen CM, Deng YJ, Yang G, Wu QJ, Wang ZY (2010) Killer cell immunoglobulin-like receptor gene diversity in the Tibetan ethnic minority group of China. Hum Immunol 71(11):1116–1123. https://doi.org/10.1016/j.humimm.2010.07.010
doi: 10.1016/j.humimm.2010.07.010 pubmed: 20650299

Auteurs

Tianju Wang (T)

HLA Typing Laboratory, Blood Center of the Shaanxi Province, Institute of Xi'an Blood Bank, Xi'an, Shaanxi, 710061, China.

Jun Qi (J)

HLA Typing Laboratory, Blood Center of the Shaanxi Province, Institute of Xi'an Blood Bank, Xi'an, Shaanxi, 710061, China. qijun0802@163.com.

Manni Wang (M)

HLA Typing Laboratory, Blood Center of the Shaanxi Province, Institute of Xi'an Blood Bank, Xi'an, Shaanxi, 710061, China.

Hua Xu (H)

HLA Typing Laboratory, Blood Center of the Shaanxi Province, Institute of Xi'an Blood Bank, Xi'an, Shaanxi, 710061, China.

Junhua Wu (J)

HLA Typing Laboratory, Blood Center of the Shaanxi Province, Institute of Xi'an Blood Bank, Xi'an, Shaanxi, 710061, China.

Lixia Shang (L)

HLA Typing Laboratory, Blood Center of the Shaanxi Province, Institute of Xi'an Blood Bank, Xi'an, Shaanxi, 710061, China.

Le Chen (L)

HLA Typing Laboratory, Blood Center of the Shaanxi Province, Institute of Xi'an Blood Bank, Xi'an, Shaanxi, 710061, China.

Yuhui Li (Y)

HLA Typing Laboratory, Blood Center of the Shaanxi Province, Institute of Xi'an Blood Bank, Xi'an, Shaanxi, 710061, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH